RoundtablesEditor's PickEditors Pick HomepagePeripheral RoundtablesPeripheralEditors Pick PeripheralLatest news PeripheralLearning AreasCX 2019Events Number of vascular surgeons being trained is “woefully inadequate”
Editor's PickInterviewsPeripheralEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralLearning AreasCX 2019Events Michel Makaroun discusses why the CX Symposium is a “special meeting”
Editor's PickInterviewsEditors Pick HomepagePeripheralEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralLearning AreasCX 2019Events Long-term partnership helps drive CX Symposium forward
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: Statistical review of methodology and legitimacy of results
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: Patient-level data from the IN.PACT Clinical Programme: Is paclitaxel safe for treatment of PAD?
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: What does Big Data tell us about survival following PAD revascularisation using drug technologies?
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: Two-year outcomes from four pooled multicentre RCTs: Safety after treatment with PTX-coated devices
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: SWEDEPAD trials – withdrawal of paclitaxel use
Editor's PickInterviewsEditors Pick HomepagePeripheralEditors Pick PeripheralLatest news PeripheralLearning AreasCX 2019Events Scientific level of CX Symposium “very attractive” for attendees
